An analytical method for determining intermediates of cycloheptatriene peptide anthelmintics

By using high-performance liquid chromatography of pentafluorophenylsilane-bonded silica gel column in the synthesis process of Emerders Intermediate 1, combined with specific mobile phases and detectors, the problem of isomer separation is solved, and the finished product yield and process optimization efficiency are improved.

CN113686978BActive Publication Date: 2025-06-13CHONGQING QIANTAI PHARMACEUTICAL RESEARCH INSTITUTE CO LTD
View PDF 2 Cites 0 Cited by

Patent Information

Application Number
CN202010424169.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2020-05-19
Publication Date
2025-06-13
Estimated Expiration
2040-05-19

AI Technical Summary

Technical Problem

The existing methods are difficult to effectively isolates of Emerders Intermediate 1, resulting in low yields of finished products.

Method used

High performance liquid chromatography using pentafluorophenylsilane-bonded silica gel column, combined with a mixed mobile phase of methanol and tetrahydrofuran water, was used for detection using an ultraviolet detector to separate and determine the purity and impurities of Emerdes Intermediate 1.

Benefits of technology

The efficient separation of the Emerders Intermediate 1 isomer is achieved, and the optimization efficiency and finished product yield of the Emerders synthesis process are improved.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FT_1
    Figure FT_1
  • Figure FT_2
    Figure FT_2
  • Figure FT_3
    Figure FT_3
Patent Text Reader

Abstract

The present invention relates to a method for determining the purity and impurities of Emendes intermediate 1 by high performance liquid chromatography, which belongs to the technical field of medicine. The technical solution is that the sample is prepared into a test solution by an appropriate method, methanol-tetrahydrofuran-water is used as the mobile phase, and the main component Emendes intermediate 1 and related impurities are separated on a pentafluorophenyl bonded silica column, and detected with a UV detector. This method can effectively separate the isomers of Emendes intermediate 1 and improve the efficiency of Emendes process optimization.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of pharmaceutical analysis, and particularly relates to an analytical method for determining the intermediate of cycloheptatriene peptide anthelmintics. Background Art

[0002] Emamectin (PF 1022-221) is a cycloheptatriene peptide with broad-spectrum anthelmintic activity. Its structural formula is as follows:

[0003]

[0004] Emamectin intermediate 1 is an intermediate produced in the first-step synthesis of emamectin, which is obtained by nitrating PF1022A. Its structure is as follows:

[0005]

[0006] The reaction system of the nitration process is very complex. In addition to the intermediate that is not completely converted during the nitro reduction process, the products also include regio-selective products. The regio-selective products of the nitration reaction are defined in Patent WO2019040585A1, mainly: the p-p, p-m, m-m, o-m products of the two benzene rings of PF1022A. Their structures are as follows:

[0007] p-p

[0008]

[0009] p-m

[0010]

[0011] m-m

[0012]

[0013] o-m

[0014]

[0015] The process of obtaining emamectin intermediate 1 by nitrating PF1022A is the key process to improve the yield of the finished product. As the target product, p-p cannot be effectively separated from p-m by the existing methods. Therefore, realizing the separation of the isomers of emamectin intermediate 1 is of great significance for optimizing the synthesis process of emamectin and improving the yield of the finished product.

[0016] Since the separation effect of general alkyl-bonded silica gel chromatographic columns on isomers is limited, a fluorinated stationary phase is used, which has stronger ion exchange and polar separation characteristics than the alkyl stationary phase. A mixed solution of methanol, tetrahydrofuran, and water is selected as the mobile phase for chromatographic analysis of emamectin intermediate 1. Summary of the Invention

[0017] The object of the present invention is to provide a high performance liquid chromatography method for separating and determining Emerdus intermediate 1, so as to realize the quality control of Emerdus intermediate 1.

[0018] The present invention is a method for determining the purity and impurities of Emerdus intermediate 1, which includes injecting a test solution of Emerdus intermediate 1 into a chromatograph with a pentafluorophenyl silane bonded silica gel column to separate and determine the purity of Emerdus intermediate 1 or its related impurities. Among them, the mobile phase is a mixture of an organic solvent and water, and the detector is an ultraviolet detector.

[0019] For the method described in the present invention, the preferred chromatographic column can be a chromatographic column with pentafluorophenyl silane bonded silica gel as the stationary phase, preferably a chromatographic column with a column length of 250 mm, a column inner diameter of 4.6 mm, and a particle size of 5 µm, and more preferably the Welch Ultimate® PFP 250 mm×4.6 mm, 5 µm chromatographic column.

[0020] In the mobile phase described in the present invention, the volume ratio of the organic solvent to purified water is 85:15 to 55:45, preferably 70:30; the organic solvent is a mixed solution of methanol and tetrahydrofuran, and the volume ratio of methanol to tetrahydrofuran is 11:9 to 13:7, preferably a volume ratio of 3:2.

[0021] The ultraviolet detection wavelength described in the present invention is 200 - 230 nm, 260 - 280 nm, preferably 210 nm, 270 nm.

[0022] The method described in the present invention further includes the following content:

[0023] (1) The column temperature of the chromatographic column is from room temperature to 40 °C, preferably 40 °C;

[0024] (2) The flow rate of the chromatographic column is 0.5 ml - 2.0 ml / min, preferably 1.0 ml / min;

[0025] (3) The concentration of the test solution is 0.5 - 2.0 mg / ml, preferably 1.0 mg / ml;

[0026] (4) The injection volume of the test solution is 5 - 50 μl, preferably 10 μl.

[0027] The present invention prepares a test solution by an appropriate method, uses methanol - tetrahydrofuran - water as the mobile phase, separates the main component Emerdus intermediate 1 and related impurities on a pentafluorophenyl silane bonded silica gel column, and detects with an ultraviolet detector. This method can effectively separate the isomers of Emerdus intermediate 1 and improve the efficiency of Emerdus process optimization. Description of the Drawings

[0028] Figure 1 The HPLC chromatogram of Example 1 is the chromatogram generated by the test sample on a phenyl-bonded silica gel chromatographic column. Chromatographic peak 1 is the overlapping peak of two groups of chromatographic peaks of p-p and p-m, chromatographic peak 2 is the overlapping peak of two groups of chromatographic peaks of m-m and m-o, and the resolution between chromatographic peaks 1 and 2 is 1.2.

[0029] Figure 2 The HPLC chromatogram of Example 2 is the chromatogram generated by the test sample on an octadecyl-bonded silica gel chromatographic column. Chromatographic peak 1 is the overlapping peak of two groups of chromatographic peaks of p-p and p-m, chromatographic peak 2 is the overlapping peak of two groups of chromatographic peaks of m-m and m-o, and the resolution between chromatographic peaks 1 and 2 is 2.1.

[0030] Figure 3 The HPLC chromatogram of Example 3 is the chromatogram generated by the test sample on an octadecyl-bonded silica gel chromatographic column. Chromatographic peak 1 is the overlapping peak of two groups of chromatographic peaks of p-p and p-m, chromatographic peak 2 is the overlapping peak of two groups of chromatographic peaks of m-m and m-o, and the resolution between chromatographic peaks 1 and 2 is 3.4.

[0031] Figure 4 The HPLC chromatogram of Example 4 is the chromatogram generated by the test sample on a pentafluorophenyl-bonded silica gel chromatographic column. Chromatographic peak 1 is the chromatographic peak of p-p, chromatographic peak 2 is the overlapping peak of three groups of chromatographic peaks of p-m, m-m and m-o, and the resolution between chromatographic peaks 1 and 2 is 1.1.

[0032] Figure 5 The HPLC chromatogram of Example 5 is the chromatogram generated under the chromatographic conditions where the mobile phase is 0.1% phosphoric acid aqueous solution and methanol. Chromatographic peak 3 is the chromatographic peak of p-p, chromatographic peak 2 is the chromatographic peak of p-m, chromatographic peak 1 is the overlapping peak of two groups of chromatographic peaks of m-m and m-o, the resolution between chromatographic peaks 1 and 2 is 0.57, and the resolution between chromatographic peaks 2 and 3 is 0.85.

[0033] Figure 6 The HPLC chromatogram of Example 6 is the chromatogram generated under the chromatographic conditions where the mobile phase is 0.1% phosphoric acid aqueous solution and methanol. Chromatographic peak 1 is the chromatographic peak of p-p, chromatographic peak 2 is the chromatographic peak of p-m, chromatographic peak 3 is the overlapping peak of two groups of chromatographic peaks of m-m and m-o, the resolution between chromatographic peaks 1 and 2 is 1.2, and the resolution between chromatographic peaks 2 and 3 is 0.72.

[0034] Figure 7 The HPLC chromatogram of Example 7 is the chromatogram generated under the chromatographic conditions where the mobile phase is 0.1% phosphoric acid aqueous solution, methanol and acetonitrile. Chromatographic peak 1 is the chromatographic peak of p-p, chromatographic peak 2 is the overlapping peak of three groups of chromatographic peaks of p-m, m-m and m-o, and the resolution between chromatographic peaks 1 and 2 is 1.3.

[0035] Figure 8 The HPLC chromatogram of Example 8 is the chromatogram generated by the test sample under the chromatographic conditions where the mobile phase is 0.1% phosphoric acid aqueous solution, tetrahydrofuran and acetonitrile. Chromatographic peak 1 is the chromatographic peak of p-p, chromatographic peak 2 is the chromatographic peak of p-m, chromatographic peak 3 is the overlapping peak of two groups of chromatographic peaks of m-m and m-o. The resolution between chromatographic peak 1 and 2 is 0.81, and the resolution between chromatographic peak 2 and 3 is 0.69.

[0036] Figure 9 The HPLC chromatogram of Example 9 is the chromatogram generated by the test sample under the chromatographic conditions where the mobile phase is 0.1% phosphoric acid aqueous solution, tetrahydrofuran and methanol. Chromatographic peak 1 is the chromatographic peak of p-p, chromatographic peak 2 is the chromatographic peak of p-m, chromatographic peak 3 is the chromatographic peak of m-m, chromatographic peak 4 is the chromatographic peak of m-m. The resolution between chromatographic peak 1 and 2 is 1.6, the resolution between chromatographic peak 2 and 3 is 1.8, and the resolution between chromatographic peak 3 and 4 is 1.4.

[0037] Implementation examples

[0038] Example 1

[0039] High performance liquid chromatograph: LC-2030C

[0040] Chromatographic column: Phenylsilane-bonded silica gel column (Agilent ZORBAX SB-Phenyl 4.6×75mm 3.5um)

[0041] Mobile phase: 0.1% phosphoric acid aqueous solution is mobile phase A; acetonitrile is mobile phase B

[0042] The elution program of mobile phase A and B is:

[0043]

[0044] Flow rate: 1.0 ml / min

[0045] Wavelength: 210 nm

[0046] Injection volume: 10 ul

[0047] Column temperature: 40 °C

[0048] Implementation steps:

[0049] Test sample solution: Take the test sample of Amides intermediate 1 and prepare a solution with a concentration of about 1.0 mg / ml.

[0050] Take 10 μl of the test sample solution and inject it into the liquid chromatograph, and record the chromatogram. The results are shown in the appendix Figure 1 .

[0051] Example 2

[0052] High performance liquid chromatograph: LC-2030C

[0053] Chromatographic column: Octadecylsilyl silica gel column (Agilent ZORBAX SB-C8 4.6×150mm 3.5um)

[0054] The mobile phase is the same as that in Example 1;

[0055] The elution program of mobile phases A and B is as follows:

[0056]

[0057] The flow rate, wavelength, injection volume and column temperature are the same as those in Example 1

[0058] Implementation steps:

[0059] Take 10 μl of the test solution in Example 1 and inject it into the liquid chromatograph, and record the chromatogram. The results are shown in the appendix Figure 2 .

[0060] Example 3

[0061] High performance liquid chromatograph: LC-2030C

[0062] Chromatographic column: Octadecylsilyl silica gel column (Ultimate ® C18, 4.6mm×250mm, 5 µm)

[0063] The mobile phase is the same as that in Example 1;

[0064] The elution program of mobile phases A and B is as follows:

[0065]

[0066] The flow rate, wavelength, injection volume and column temperature are the same as those in Example 1

[0067] Implementation steps:

[0068] Take 10 μl of the test solution in Example 1 and inject it into the liquid chromatograph, and record the chromatogram. The results are shown in the appendix Figure 3 .

[0069] Example 4

[0070] High performance liquid chromatograph: Agilent1260

[0071] Chromatographic column: Pentafluorophenylsilyl silica gel column (Ultimate ® PFP, 4.6mm×250mm, 5 µm)

[0072] The mobile phase is the same as that in Example 1;

[0073] The elution procedures for mobile phases A and B are as follows:

[0074]

[0075] The flow rate, wavelength, injection volume, and column temperature are the same as in Example 1

[0076] Implementation steps:

[0077] Inject 10 μl of the test solution under Example 1 into the liquid chromatograph and record the chromatogram. The results are shown in the appendix Figure 4 .

[0078] Example 5

[0079] High-performance liquid chromatograph: Agilent1260

[0080] The chromatographic column is the same as in Example 4

[0081] Mobile phase: 0.1% phosphoric acid aqueous solution is mobile phase A; methanol is mobile phase B

[0082] The elution procedures for mobile phases A and B are as follows:

[0083]

[0084] The flow rate, injection volume, and column temperature are the same as in Example 1

[0085] Wavelength: 270 nm

[0086] Implementation steps:

[0087] Inject 10 μl of the test solution under Example 1 into the liquid chromatograph and record the chromatogram. The results are shown in the appendix Figure 5 .

[0088] Example 6

[0089] High-performance liquid chromatograph: Agilent1260

[0090] The chromatographic column is the same as in Example 4

[0091] Mobile phase: 0.1% phosphoric acid aqueous solution is mobile phase A; tetrahydrofuran is mobile phase B

[0092] The elution procedures for mobile phases A and B are as follows:

[0093]

[0094] The flow rate, wavelength, injection volume, and column temperature are the same as in Example 5

[0095] Implementation steps:

[0096] Inject 10 μl of the test solution under Example 1 into the liquid chromatograph and record the chromatogram. The results are shown in the appendix Figure 6。

[0097] Example 7

[0098] High performance liquid chromatograph: Agilent1260

[0099] The chromatographic column is the same as that in Example 4

[0100] Mobile phase: water is mobile phase A; methanol - acetonitrile (1:1) (v / v) is mobile phase B

[0101] The elution program of mobile phases A and B is as follows:

[0102]

[0103] The flow rate, wavelength, injection volume and column temperature are the same as those in Example 5

[0104] Implementation steps:

[0105] Take 10 μl of the test solution in Example 1 and inject it into the liquid chromatograph, and record the chromatogram. The results are shown in the appendix Figure 7 。

[0106] Example 8

[0107] High performance liquid chromatograph: Agilent1260

[0108] The chromatographic column is the same as that in Example 4

[0109] Mobile phase: water is mobile phase A; tetrahydrofuran - acetonitrile (3:4) (v / v) is mobile phase B

[0110] The elution program of mobile phases A and B is as follows:

[0111]

[0112] The flow rate, wavelength, injection volume and column temperature are the same as those in Example 5

[0113] Implementation steps:

[0114] Take 10 μl of the test solution in Example 1 and inject it into the liquid chromatograph, and record the chromatogram. The results are shown in the appendix Figure 8 。

[0115] Example 9

[0116] High performance liquid chromatograph: Agilent1260

[0117] The chromatographic column is the same as that in Example 4

[0118] Mobile phase: water is mobile phase A; tetrahydrofuran - methanol (2:3) (v / v) is mobile phase B

[0119] The elution program of mobile phases A and B is as follows:

[0120]

[0121] The flow rate, wavelength, sample injection volume and column temperature are the same as those in Example 5

[0122] Implementation steps:

[0123] Inject 10 μl of the test solution in Example 1 into the liquid chromatograph and record the chromatogram. The results are shown in the appendix Figure 9 .

Claims

1. A method for determining the purity and impurities of Amides intermediate 1, characterized in that: the chromatographic column is a chromatographic column filled with pentafluorophenyl silane-bonded silica gel; the detector is an ultraviolet detector; wherein, the structure of Amides intermediate 1 is as follows: ; the structures of the impurities are as follows: p-m 、 m-m 、 o-m ; mobile phase: water is mobile phase A; a mixed solution of tetrahydrofuran-methanol is mobile phase B; the volume ratio of the tetrahydrofuran to the methanol is 2:3; the elution program of mobile phases A and B is: 。 2. The method according to claim 1, wherein the chromatographic column is a chromatographic column with a column length of 250 mm, a column inner diameter of 4.6 mm, and a particle size of 5 µm.

3. The method according to claim 1 or 2, characterized in that the detection wavelength is 200-230 nm, 260-280 nm.

4. The method according to claim 3, characterized in that the column temperature of the chromatographic column is from room temperature to 40 °C.

5. The method according to claim 4, characterized in that the flow rate of the chromatographic column is 0.5 ml - 2.0 ml / min.

6. The method according to claim 5, characterized in that the concentration of the test solution is 0.5 - 2.0 mg / ml.

7. The method according to claim 6, characterized in that the injection volume of the test solution is 5 - 50 ul.

Citation Information

Patent Citations

  • Methods for production of PF1022a derivatives and flow platforms useful for the same

    WO2019040585A1

  • PF1022A separating and purifying method

    CN106749569A